U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909070) titled 'A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment' on Oct. 26.
Brief Summary: The primary purpose of this study is to evaluate the plasma PK of JMKX003142 following a single dose in participants with mild and moderate hepatic impairment compared to matched healthy participants with normal hepatic function.
Study Start Date: Nov. 20
Study Type: INTERVENTIONAL
Condition:
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Renal Edema
Intervention:
DRUG: JMKX003142
Single oral dose of JMKX003142 in participants from all groups
Recruitment Status: NOT_YET_R...